1-20 of 185
pneumonia, pneumocystis carinii
Close
Sort by
Journal Articles

Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (iFCG) for First-Line Treatment of IGHV -Mutated CLL and without Del(17p)/Mutated TP53

Nitin Jain, MD, Philip A. Thompson, MBBS, Jan A. Burger, MD PhD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Zeev E. Estrov, MD, Gautam M. Borthakur, MD, Prithviraj Bose, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Koji Sasaki, MD, Naveen Garg, MD, Xuemei Wang, MS, Rashmi Kanagal-Shamanna, MD, Keyur Patel, MD PhD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Wanda Lopez, RN, Ana Ayala, RN, William Plunkett, PhD, Varsha Gandhi, PhD, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Michael J Keating, MBBS, William G. Wierda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 357.
https://doi.org/10.1182/blood-2019-131939
Published: 2019
Journal Articles

Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years

Christopher A. Yasenchak, MD, Rodolfo Bordoni, MD, Victor Yazbeck, MD, Dipti Patel-Donnelly, MD, Thomas Anderson, Timothy Larson, MD, Trevor Newhook, MS, Matthew Mei, MD, Linda Ho, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 237.
https://doi.org/10.1182/blood-2019-124866
Published: 2019
Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5242.
https://doi.org/10.1182/blood-2019-124597
Published: 2019
Journal Articles

Risk of Serious Adverse Events, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Treated with Idelalisib

Jonathan Kopel, BS, Sriman Swarup, MDMBBS, Anita Sultan, MD, Lukman Tijani, MD, Ei Moe Phyu, MD, Myint Aung Win, MDMBBS, Thura Win Htut, MBBS, MRCP, Ye Aung, Akshar Dash, Myat Min Han, MD, Yin Mon Myat, MD, Donald P. Quick, MD, Nicholas D'Cunha, MD, Kyaw Zin Thein, MDMBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5489.
https://doi.org/10.1182/blood-2019-123179
Published: 2019
Journal Articles

Lenalidomide and Rituximab Maintenance Therapy after Front-Line Induction Chemoimmunotherapy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Julie E Chang, MD, Vaishalee P. Kenkre, MD, Christopher D. Fletcher, MD, Aric C. Hall, MD, Natalie Scott Callander, MD, Kyungmann Kim, PhD, Grace Yi Chen, Kaitlin Chambers
Journal: Blood
Blood (2019) 134 (Supplement_1): 5470.
https://doi.org/10.1182/blood-2019-124489
Published: 2019
Journal Articles

Retrospective Non-Interventional Assessment of the Use of Idelalisib in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Spain

Christelle M Ferra, Manuel Perez Encinas, MD, Javier Lopez Jimenez, MD, Macarena Ortiz, MD, Santiago Osorio-Prendes, MD, Raul Cordoba, MD PhD, Angel Ramirez Payer, Eva González-Barca, MD PhD, Guillermo Martín Sánchez, MD, Marcos Gonzalez Diaz, MD, Maria Jose Sanchez, MD, Margarita Fernandez, MD, Patricia Baltasar Tello, MD, Elena Amutio, MD, María-Dolores García-Malo, MD, Maria Jesus Vidal Maceñido, MD, Pascual Fernandez, MD, Javier Loscertales, MD, Juan Nicolás Rodríguez, MD, Concha Alaez, MD, Heribert Ramroth, PhD, Margarida Palla
Journal: Blood
Blood (2019) 134 (Supplement_1): 5473.
https://doi.org/10.1182/blood-2019-126588
Published: 2019
Journal Articles

Follicular Lymphoma Frontline Immuno-Chemotherapy: Survival Outcomes and Infection-Related Morbidity

Faouzi Djebbari, Furqaan Kaji, Louise Stanton, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Toby A. Eyre
Journal: Blood
Blood (2019) 134 (Supplement_1): 5884.
https://doi.org/10.1182/blood-2019-122213
Published: 2019
Journal Articles

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MDMSc, Mary Murph, Christopher Wells, Ifeyinwa (ify) Osunkwo, MDMPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 5862.
https://doi.org/10.1182/blood-2019-123215
Published: 2019
Journal Articles

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Melanie T Cushion, PhD MS, Alan Ashbaugh, Voon Ong, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3266.
https://doi.org/10.1182/blood-2019-127392
Published: 2019
Journal Articles

Hydroxyurea Prescription Fills and Adherence, Among Pediatric and Adult Medicaid Eligible Patients with Sickle Cell Disease in North Carolina

Nirmish Shah, Christian Douglas, DrPH, Nancy Crego, PhD RN, CCRN, CHSE, Emily Bonnabeau, BA, Marian Earls, MD, Kern Eason, MBA, Elizabeth Merwin, PhD RN, FAAN, Paula Tanabe, PhDRN
Journal: Blood
Blood (2019) 134 (Supplement_1): 3391.
https://doi.org/10.1182/blood-2019-124442
Published: 2019
Journal Articles

Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive Chemotherapy

Jason N Barreto, PharmD, Carrie A. Thompson, MD, Kristin C. Mara, MS., Amanda G Sierzchulski, PharmD, Ashley L Potter, PharmD, Pritish K Tosh, MD, Andrew H Limper, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4052.
https://doi.org/10.1182/blood-2019-122060
Published: 2019
Journal Articles

Results of a First in Human, Dose Ascending, Phase I Study Examining the Safety and Tolerability of KA2237, an Oral PI3K p110β/δ Inhibitor in Patients with Relapsed/Refractory (R/R) B-Cell Lymphoma

Loretta J. Nastoupil, MD MSc, Sattva S Neelapu, MD, Eric Davis, MD, Felipe Samaniego, MD, Nathan H Fowler, MD, Jason R. Westin, MD, Hun Ju Lee, Michael Wang, MD, Fredrick B. Hagemeister, MD, Philip Beer, MD PhD, Alexander R. L. Cecil, James Dow, Duncan McHale, Franck Silva, Penny Ward, Arash Yavari, Stephen Joseph Shuttleworth, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4099.
https://doi.org/10.1182/blood-2019-130401
Published: 2019
Journal Articles

Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting

David Andorsky, MD, Rebecca J Chan, MD PhD, Jamyia Clark, MPH, Bianca Ruzicka, PhD, Nicholas James Robert, MD, Farrukh T. Awan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2810.
https://doi.org/10.1182/blood-2019-124013
Published: 2019
Journal Articles

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2101.
https://doi.org/10.1182/blood-2019-122255
Published: 2019
Journal Articles

Phase Ib of Copanlisib in Combination with Ibrutinib in Recurrent/Refractory Primary CNS Lymphoma (PCNSL)

Christian Grommes, MD, Igor Gavrilovic, MD, Alexandra M Miller, MD PhD, Jacqueline B Stone, MD, Thomas Kaley, MD, Juli T Madzsar, Alyssa Schumpp, Brittany T Butler, Lauren Schaff, MD, Ingo K Mellinghoff, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1598.
https://doi.org/10.1182/blood-2019-126214
Published: 2019
Journal Articles

A Multicentre, Retrospective Observational Study to Evaluate the Clinical Outcomes of Patients with Chronic Lymphocytic Leukaemia (CLL) Treated with Idelalisib and Rituximab in the UK (RETRO-idel) - a Cohort of 110 Patients

Toby A. Eyre, Gavin Preston, MD, Huseini Hatimbhai Kagdi, MD PhD MBBS, FRCPath, MRCP, Amin Islam, MD, Toby Nicholson, FRCPath, MBBS, MRCP, BA, Christopher Fegan, MB, MD FRCP, FRCPath, Harry W Smith, BSc, MSc, Adam P Cursley, MSc, Heribert Ramroth, PhD, Nishan Rajakumaraswamy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1762.
https://doi.org/10.1182/blood-2019-126845
Published: 2019
Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4768.
https://doi.org/10.1182/blood-2019-128139
Published: 2019
Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4626.
https://doi.org/10.1182/blood-2019-127950
Published: 2019
Journal Articles

Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Treated with Phosphatidylinositol 3-Kinase (PI3K) Inhibitors

Sriman Swarup, MDMBBS, Donald P. Quick, MD, Anita Sultan, MD, Myint Aung Win, MDMBBS, Ei Moe Phyu, MD, Thura Win Htut, MBBS, MRCP, Sariya Wongsaengsak, MD, Myet Mon Zin, MD, Myat Min Han, MD, Yin Mon Myat, MD, Sanjay Awasthi, MD, Lukman Tijani, MD, Kyaw Zin Thein, MDMBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 798.
https://doi.org/10.1182/blood-2019-123177
Published: 2019
Journal Articles

Elotuzumab As Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Myeloma

Nikhita Gadi, MDMSc, Linda Schmidt, RN, Jaeil Ahn, PhD, Tianmin Wu, MS, Scott D. Rowley, MD, Elli Gourna Paleoudis, PhD, Michele L. Donato, MD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, David S. Siegel, Noa Biran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3141.
https://doi.org/10.1182/blood-2019-129504
Published: 2019